Thyroid eye disease (TED) is a complex autoimmune disorder and the most common extrathyroidal manifestation of Graves’ disease, characterized by orbital inflammation, tissue remodelling, and varying degrees of functional and cosmetic impairment. Although often mild, moderate-to-severe and sight-threatening forms can si...
G. Markantes, G. Effraimidis, O. Karapanou et al.· Drugs in Context· 1 citation
Background Rare genetic forms of obesity are characterized by severe, early-onset obesity and hyperphagia, often involving the leptin–melanocortin pathway. Although advances in genetic testing have improved the recognition of monogenic obesity, data from Southern European populations remain limited. We investigated the...
E. Kostopoulou, D. X. Spilioti, Nikolaos D. Pantzaris et al.· Obesity Pillars· 0 citations
Background/Objectives: This study evaluated the metabolic effects of empagliflozin, an SGLT2 inhibitor (SGLT2i), in type 2 diabetes patients. Methods: In an observational cohort study, 42 patients received empagliflozin for 1 month, with serum and urine analyzed for IL-6, NT-proBNP, iron metabolism markers, and electro...
Evagelia E. Habeos, G. Markantes, Anastasia Parthymou et al.· Biomedicines· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
